· Co-founder and CEO of Glyphic Biotechnologies, a Seed-stage biotech startup developing next-generation protein sequencing.
· Co-founder of Nephrosant, a Series A-stage diagnostics biotech startup commercializing non-invasive kidney disease diagnostics.
· MBA @ Stanford Graduate School of Business
· MD-PhD candidate @ Johns Hopkins University School of Medicine and Department of Biomedical Engineering
· M.Eng. in Translational Medicine @ UC San Francisco and UC Berkeley
· B.S. in Bioengineering: Biotechnology and B.S. in General Biology @ UC San Diego
· Forbes 30 Under 30 Healthcare
· Biocom California's Life Science Catalyst Award
· Email: firstname.lastname@example.org
· Professional Profile: LinkedIn
· Research Publications: Google Scholar
· CV: PDF
· Twitter: @joshuayoungyang
· I was selected as one of Biocom California's Life Science Catalyst Award winners, recognizing those who are making their mark on the California life science industry before reaching their 40th birthday
· I graduated from the Stanford Graduate School of Business as the Henry Ford II Scholar (Valedictorian) and as an Arjay Miller Scholar (Top 10%).
· I was listed on the 2021 Best & Brightest MBAs list by Poets & Quants.
· I was named as a Forbes 30 Under 30 on their 2021 Healthcare list.
· I was awarded a grant by the Roddenbury Foundation from their Catalyst Fund to validate Cerviscope's cervical cancer screening technology.
· My team and I won 1st place at the Merck Innovation Cup 2020 for our proposal for a novel drug discovery platform, having been selected out of over 2,000 applicants.
· My perspective piece titled, A Pandemic of Loneliness, was published in Doximity's Op-Med.
· My article on how to find fellowships and scholarships for graduate school was published by Sallie Mae on their Within Reach blog.
· Our global health project Cerviscope won 2nd place at the Johns Hopkins Healthcare Design Competition and was a finalist for the Bisciotti Student Entrepreneurship Award
· My first-author publication on Nephrosant's QSant Assay was published in Science Translational Medicine
· My startup Nephrosant and I were featured in GenomeWeb about the upcoming launch of our QSant assay.
· I was featured in Poets & Quants 'Meet Stanford GSB's MBA Class of 2021'